New therapeutic options for HCV infection in the monoclonal antibody era. | New Microbiol;35(4): 387-97, 2012 Oct. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

New therapeutic options for HCV infection in the monoclonal antibody era.

Sautto, Giuseppe Andrea; Diotti, Roberta Antonia; Clementi, Massimo.

Affiliation

Sautto GA; Laboratory of Microbiology and Virology, Universita Vita-Salute San Raffaele, Milano, Italy. sautto.giuseppe@hsr.it

New Microbiol ; 35(4): 387-97, 2012 Oct.

Article in En | MEDLINE | ID: mdl-23109006

Subject(s)

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Hepatitis C / Hepacivirus / Hepatitis C Antibodies / Antibodies, Monoclonal Limits: Animals / Humans Language: En Journal: New Microbiol Journal subject: MICROBIOLOGIA Year: 2012 Document type: Article Affiliation country: Country of publication:

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Hepatitis C / Hepacivirus / Hepatitis C Antibodies / Antibodies, Monoclonal Limits: Animals / Humans Language: En Journal: New Microbiol Journal subject: MICROBIOLOGIA Year: 2012 Document type: Article Affiliation country: Country of publication: